Surface Hopping Molecular Dynamics Simulations for Photochemistry Involving Pyrene and CH₃Cl av Elham Mazarei (4508746)

Ämnen:

Claudin-5 is involved in one of the main proteins that control the blood-brain barrier (BBB). av Zhizhong Wang (838758)

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings. av Diana M. Hendrickx (1507435)

Participants’ perceptions of the likelihood of being harmed when receiving hospital or ambulatory care from 2019 to 2023 (N = 1000 per year). av Olga Amberger (20299807)

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings when using the persistent CMA group as a reference. av Diana M. Hendrickx (1507435)

LOESS curves of participants’ perceptions of the likelihood of being harmed when receiving hospital or ambulatory care from 2019 to 2023 (N = 1000 per year). av Olga Amberger (20299807)

Spatial distribution of overall non-carcinogenic risk (HI) for (a) infants, (b) Children, (c) adult females, and (d) adult males posed by potential harmful substances of groundwate... av Shanhu Xiao (22226759)

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. av Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. av Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. av Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. av Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. av Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. av Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. av Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. av Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... av Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. av Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB. av Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determ... av Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB. av Diana M. Hendrickx (1507435)